Ocular Therapeutix launches Phase III trial for eye plug

Ophthalmic devices maker Ocular Therapeutix begins Phase III human trials of its sustained-release dexamethasone eye plug in patients undergoing cataract surgery.

Bedford, mass.-based Ocular Therapeutix launched Phase III human clinical studies of its drug-releasing optical plug in patients undergoing cataract surgery.

Ocular Therapeutix Inc.

News Well, Clinical Trials, Drug-Device Combinations, Optical/Ophthalmic

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1g09K6I